2 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Oncogenic osteomalacia: new trials by email Literature Review of Oncogenic osteomalacia trials Research Report on Oncogenic osteomalacia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BGJ398 for the Treatment of Tumor-Induced Osteomalacia BGJ398 - Tumor-Induced Osteomalacia, Oncogenic Osteomalacia | Phase 2 | Terminated | National Institute of Dental and Craniofacial Research (NIDCR) | 4 | 2019-02-27 | 2026-11-10 |
| A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome KRN23 - Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome | Phase 2 | Completed | Kyowa Kirin Co., Ltd. | 14 | 2016-04-01 | 2022-09-06 |
| Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS) Burosumab - Tumor Induced Osteomalacia (TIO), Epidermal Nevus Syndrome (ENS) | Phase 2 | Completed | Kyowa Kirin, Inc. | 17 | 2015-03-24 | 2024-05-06 |
Nevus, Sebaceous of Jadassohn (2) · Hypophosphatemia (1)
Abnormalities, Multiple (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Nervous System Diseases (2) · Neurocutaneous Syndromes (2) · Nevi and Melanomas (2) · Nevus (2) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Phosphorus Metabolism Disorders (1)
burosumab (2) · infigratinib (1)
Kyowa Kirin Co., Ltd. (1) · Kyowa Kirin, Inc. (1) · National Institute of Dental and Craniofacial Research (NIDCR) (1)
United States (2) · Japan (1) · South Korea (1)